CONNECTED HEALTH CONFERENCE • Boston, MA • October 25-27, 2017
How do we gather more high-quality data needed to drive clinical oncology research?
The Integrating Clinical Trials and Real Word Endpoints (ICARE)data project is testing an innovative approach to do exactly that.
Today’s gold source of data for oncology research is randomized controlled trials (RCTs). While this data is high quality, it is insufficient because only approximately 3% of cancer patients in the U.S. enroll in clinical trials. How does one collect data on these patients after the clinical trial ends? What about the other 97% of cancer patients? Their data is contained in electronic health record (EHR) clinical notes which tell the patient’s story but are not structured.
About Mary Pulvermacher
Mary Pulvermacher is a Senior Principal Engineer in the Information Technology Technical Center within The MITRE Corporation. She is a technical leader with over 30 years of experience defining and developing advanced, customer-focused, information technology systems solutions.